December 2024: Alaa Farghli’s thesis work on single-cell analysis of fibrolamellar carcinoma tumors is now on bioRxiv. Congrats, Alaa, on this magnum opus!
November 2024: Congratulations to Alexx on the successful defense of her thesis on microRNAs and inflammatory bowel disease!! Great work, Alexx, so glad you’re staying with us for a short post-doc.
October 2024: Alaa completes his short-term post-doc with us after an excellent PhD thesis project on single-cell multi-omic analysis of fibrolamellar carcinoma. Congratulations, Alaa!!
September 2024: Alexx and Mike presented and represented our lab at the GI FASEB meeting in Banff — proud of you both — an all-around stellar job and great to see Paneth cells get some love!
August 2024: Delighted to share here Don’s lead-author paper on re-wired tumor metabolism in fibrolamellar carcinoma, published in Cell Reports Medicine. Great work, Don, and congratulations to you and all co-authors!
July 2024: Our 12+ year collaborative study with the Deshmukh lab (UNC) on the role of miR-29 in driving aging-related traits has been accepted at Communications Biology!
June 2024: We’re delighted for Elizabeth Negron, REU scholar, to join us this summer for her research experience on microRNAs and intestinal epithelial tuft cells.
May 2024: Congratulations to Sara and Ramin on their graduation!! We have been so lucky to have them in our lab these past few years, and I’m excited for their next steps in med school and beyond.
April 2024: Delighted to share our work on the role of non-coding RNA LINC00473 in fibrolamellar carcinoma – congratulations to lead-author Dr. Rosanna Ma and many outstanding collaborators in the lab and across the country. Highlighted by CVM news here.
March 2024: Congratulations to Dr. Kieran Koch-Laskowski on the publication of her lead-author paper on single-cell analysis of intestinal epithelial adaptations to bariatric surgery – great collaboration with Darleen’s Sandoval group! Check out Kieran and her work highlighted by the NIH here.
February 2024: Aberrant miR-29 is a predictive feature of severe phenotypes in pediatric Crohn’s disease – congrats to lead-authors Alexx Shumway and Dr. Mike Shanahan, and to all of our excellent UNC collaborators! Highlighted by Cornell Chronicle here.
January 2024: Check out Praveen as a guest on the Cornell Vet Podcast!
Archives:
Lab News 2023
Lab News 2022
Lab News 2021
Lab News 2020
Lab News 2019
Lab News 2018
Lab News 2017
Lab News 2016